UK's MHRA Approved An Adapted Pfizer/BioNTech Covid-19 Vaccine (Comirnaty) That Targets The JN.1 Covid-19 Subvariant; Four Forms Of This Adapted Comirnaty JN.1 Vaccine Have Been Approved
UK's MHRA Approved An Adapted Pfizer/BioNTech Covid-19 Vaccine (Comirnaty) That Targets The JN.1 Covid-19 Subvariant; Four Forms Of This Adapted Comirnaty JN.1 Vaccine Have Been Approved
英國藥品及醫療保健管理局批准了一種經過改良的輝瑞/biontech新冠疫苗(Comirnaty)，針對JN.1新冠亞型；這種改良的Comirnaty JN.1疫苗有四種形式獲得批准
UK's MHRA Approved An Adapted Pfizer/BioNTech Covid-19 Vaccine (Comirnaty) That Targets The JN.1 Covid-19 Subvariant; Four Forms Of This Adapted Comirnaty JN.1 Vaccine Have Been Approved
英國藥品及醫療保健管理局批准了一種經過改良的輝瑞/biontech新冠疫苗(Comirnaty)，針對JN.1新冠亞型；這種改良的Comirnaty JN.1疫苗有四種形式獲得批准
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。